The effect of thyroid
It is generally accepted that children with hypothyroidism show retarded growth and their growth patterns improve after successful treatment. Growth is a complicated phenomenon and there are a number of factors which influence growth in children. Somatomedin is widely known to stimulate growth of cartilage and is accepted as being one of the growth factors responsible for human growth (Daughaday et al., 1975) . There is no doubt that serum somatomedin levels are growth hormone dependent (Daughaday et al., 1972) . However, there are several reports which indicate that somatomedin may also be regulated by the nutritional status (Phillips and Young 1976a , 1979a , insulin (Daughaday et al., 1976 , Phillips and Young 1976b , Takano et al. 1979b ), prolactin (Denko 1959 , Francis and Hill 1975 , Holder and Wallis 1977 , ovine placental lactogen (Hurley et al., 1977) , thyroxine (Mosier et al., 1977 , Gaspard et al., 1978 , estrogen Schwartz 1972, Wiedemann et al., 1976; Saenger et al., 1976) and androgen (LundLarsen et al., 1977; Kawai et al., 1979) . In most of these studies somatomedin activity has been measured using a bioassay based on the ability of serum samples to stimulate the uptake of 35S-labelled sulphate into chondroitin sulphate or thymidine incorporation into DNA in cartilage (Daug haday et al., 1975) .
It has been reported that thyroid hormone causes a rapid stimulation of sulp- hation in chick cartilage in combination with an unidentified factor or factors in serum (Audhya and Gibson, 1975) . In the present study we have fowl, hat serum levels of somatomedin A deteiniifted by radioreceptor assay are significantly lower in patients with primary hypothyroidism than those in euthyroid subjects. This observation prompted us to investigate the role of thyroxine on somatomedin generation by growth Lormone in thyroidectomized as wei a hyi,ophysectomized rats. The growth hormone preparation used for this study was a highly purified human growth hormone: Crescormon(R), obtained from AB Kabi/Recip, Stockholm, Sweden. This preparation contains 2 IU per mg, and is essentially free from ACTH, FSH, LH, TSH, vasopressin, oxytocin, and polymers of hGH. The thyroxine preparation used for this study was L-thyroxine (No. T-2376) obtained from Sigma, St. Louis, U. S. A.
Methods
Serum somatomedin A was determined by the radioreceptor assay described previously (Hall et al., 1974; Takano et al., 1975 Takano et al., , 1976 Takano et al., , 1977 Takano et al., , 1979c . The somatomedin A used for labelling was purified by Dr. L. Fryklund at Recip polypeptide Laboratory, AB Kabi, Stockholm, and had a biological activity of 1,000 U/mg as determined by radioreceptor assay for somatomedin A. Currently, there is no uniform standard substance for the radioreceptor assay and pooled human sera have been used as an arbitrary reference in various laboratories.
We therefore used our pooled serum as a reference serum and one unit (U) of somatomedin A is defined here as the somatomedin content in one ml of this pooled serum. The data presented are given relative to this local arbitrary unit.
This radioreceptor assay for somatomedin A not only measures the polypeptide somatomedin A but also, to some extent, biologically related polypeptides such as somatomedin-C (Hall et al., 1975) , multiplication stimulating activity ) and insulin-like growth factor (Hall and Fryklund, 1979) . Furthermore, somatomedin binding protein in serum interacts with the radioreceptor assay (Chochinov et al., 1977) . The intra-and interassay variations in repeated measurements on the same sample were 11.7% and 15.7%, respectively. Student's t-test was used for statistical analysis. Correlation coefficients between percent increases in serum somatomedin A and body weight from initial values were calculated by the least squares method.
Commercial radioimmunoassay kits were used to determine serum T3, TSH, hGH, (Eiken Immuno Chemical Co., Ltd.) and T4 (Kaken Chemical Co ., Ltd.). Resin T3 uptake was determined using a Triosorb(R) Kit (Abbot-Dinabot).
Anti-thyroglobulin and antimicrosomal antibodies were tested by hemagglutination, using reagent kits (Thyroid test, Fujizoki Pharmaceutical Co., Ltd. for anti-thyroglobulin antibody and Microsome test, Fujizoki Pharmaceutical Co., Ltd., for antimicrosomal antibody). When the correlations between serum somatomedin A and the percent increase in body weight were calculated in these rats altogether, there was a positive correlation between these two values as shown in Fig.  3 (r=0.73, p<0.001, N=43) .
The mean total caloric intake during the 7 days in the rats treated with saline, GH, T4 and GH+T4 was 185, 186, 200 and 202 Cal per rat, respectively and that during the 14 days was 315, 327, 361, 454 Cal per rat, respectively. The total caloric intake in T4 treated rats was greater than in rats treated with saline or GH.
Discussion
The serum levels of somatomedin A were within the normal range in patients with hyperthyroidism, but the levels were lower in patients with hypothyroidism than in normal subjects. These findings confirm earlier results (Van den Brande and Du Caju, 1974; D'Ercole et al., 1977; Draznin et al., 1980) . After the treatment with thyroxine, the serum levels of somatomedin A returned to the normal range. There was a significant correlation between serum levels of somatomedin A and T3, T4 and log TSH. These data suggest that thyroid hormone is necessary to maintain serum levels of somatomedin A. The role of thyroid hormone was further examined using rats.
The levels of somatomedin A had not changed significantly 7 days after thyroidectomy in rats. We reported that level of somatomedin A is low at birth and gradually increases with age until the age of 60 day in rats (Hizuka et al., 1979) . Therefore, thyroidectomy might have inhibited a a further increase in somatomedin A in our study. There are some reports that serum levels of IGF decrease significantly in rats Endocrinol. Japon. October 1980 after treatment with propylthiouracil (PTU) for 17 days or 35 days, respectively (Mosier et al., 1977 , Burstein et al ., 1979 . Therefore, the period (7 days) might have been not long enough to detect a significant decrease in serum somatomedin A in our study.
No effect of thyroxine on serum levels of somatomedin A was observed in hypophysectomized rats. Our observation thus differs from those reported by Holder and Wallis (1977) or Gaspard et al . (1978) . They observed increased levels of somatomedin activity after injection of 2 pg/rat of thyroxine for 21-24 days in hypophysectomized rats. However , Daughaday et al. reported that the administration of 0.5 mg bovine GH/day to hypothyroid rats did not restore the levels of somatomedin . We found that the combined administration of thyroxine and GH resulted in a greater increase in serum somatomedin A than GH treatment alone , which is in agreement with the results reported by Schalch et al . (Phillips et al., 1976a (Phillips et al., , 1978 Takano et al., , 1979 (Root et al., 1967; Brauman and Corvilain 1968; Bigos et al., 1978., Fink; Iwatsubo et al., 1967) . After treatment with thyroid hormone , the secretion of GH improved (Iwatsubo et al ., 1967; Chester 1967) . Thyroid hormone stimulates rGH synthesis (Hervas et al ., 1975) and GH mRNA activity in vitro Seo et al., 1977 Seo et al., , 1978 Seo et al., , 1979 Shapiro et al., 1978) . From these observations it is clear that thyroxine stimulates GH synthesis at the pituitary level. Thyroid hormone in vitro, in combination with a factor in serum, causes a rapid stimulation of sulphation in chick embryo Cartilage (Audhya and Gibson., 1975) and has an effect on the maturation of the skelton (Simpson et al., 1950; Ray et al., 1954; Asling et al., 1968) . Cell culture studies have indicated the need for thyroid hormone for chondrogenesis (Pawelek, 1969; Toole, 1973) . These observations indicate that thyroid hormone has adirect effect on bone maturation. In addition to these effects our studies as well as others demonstrated that thyroid hormone has a potentiating effect on GHinduced somatomedin synthesis, and/or secretion in hypophysectomized rats. However the precise mechanism of this potentiating effect remains to be clarified.
